Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
  • News

An Innovative Approach to Efficient Anti-Cancer Drug Synthesis

  • The Pharma Data
  • December 9, 2024

The Horner-Wadsworth-Emmons (HWE) reaction is a fundamental reaction in organic chemistry, widely used to create conjugated carbonyl compounds. Conjugated carbonyl compounds are used in many industries for synthesizing perfumes, plastics,…

Read MoreAn Innovative Approach to Efficient Anti-Cancer Drug Synthesis
  • Press ReleasesResearch

Stoke Therapeutics Presents Data Supporting Zorevunersen as Treatment for Dravet Syndrome

  • The Pharma Data
  • December 7, 2024

Stoke Therapeutics has announced new data from its Phase 1/2a and open-label extension (OLE) studies on zorevunersen, a potential disease-modifying treatment for Dravet syndrome. The data revealed significant and lasting…

Read MoreStoke Therapeutics Presents Data Supporting Zorevunersen as Treatment for Dravet Syndrome
  • Research

Alithea Genomics Unveils Full-Length DRUG-Seq to Enhance Transcriptomics in Drug Discovery

  • The Pharma Data
  • December 7, 2024

Alithea Genomics, a leading innovator in large-scale RNA sequencing and transcriptomics, has unveiled its latest technological advancement: the MERCURIUS™ Full-Length DRUG-seq library preparation platform. This new solution represents a groundbreaking…

Read MoreAlithea Genomics Unveils Full-Length DRUG-Seq to Enhance Transcriptomics in Drug Discovery
  • Research

Children’s Hospital Los Angeles Marks 100th Retinal Gene Therapy Procedure

  • The Pharma Data
  • December 7, 2024

At Children’s Hospital Los Angeles Dr. Aaron Nagiel, MD, PhD, has witnessed firsthand the profound impact of retinal gene therapy on children with Leber congenital amaurosis (LCA), a rare genetic…

Read MoreChildren’s Hospital Los Angeles Marks 100th Retinal Gene Therapy Procedure
  • News

IMFINZI Receives Priority Review in US for Muscle-Invasive Bladder Cancer

  • The Pharma Data
  • December 7, 2024

AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics License Application (sBLA) for IMFINZI® (durvalumab) and granted it Priority Review. The application seeks approval…

Read MoreIMFINZI Receives Priority Review in US for Muscle-Invasive Bladder Cancer
  • Regulatory

Senegal and Rwanda Attain WHO Maturity Level 3 for Medicines Regulation

  • The Pharma Data
  • December 7, 2024

Senegal and Rwanda have joined an elite group of African nations by achieving Maturity Level 3 (ML3) status in the World Health Organization’s (WHO) global classification of national regulatory authorities.…

Read MoreSenegal and Rwanda Attain WHO Maturity Level 3 for Medicines Regulation
  • News

Webinar Leveraging Digital and Analytics Tools in Mpox Response

  • The Pharma Data
  • December 7, 2024

Between January 2022 and October 2024, over 120 countries reported cases of mpox, marking a significant multi-country outbreak that impacted all WHO regions. In response, public health professionals convened in…

Read MoreWebinar Leveraging Digital and Analytics Tools in Mpox Response
  • Press Releases

LEQEMBI (Lecanemab) Gains Approval in Mexico for Early Alzheimer’s Treatment

  • The Pharma Data
  • December 7, 2024

Eisai and Biogen Inc. have announced that Mexico’s Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) has approved LEQEMBI (lecanemab), a humanized monoclonal antibody, for the treatment of early…

Read MoreLEQEMBI (Lecanemab) Gains Approval in Mexico for Early Alzheimer’s Treatment
  • News

EU Approves Novo Holdings’ Catalent Acquisition and Novo Nordisk’s Site Purchase

  • The Pharma Data
  • December 7, 2024

Today, the European Commission officially approved the acquisition of Catalent, Inc. by Novo Holdings A/S, a deal that will further expand the capabilities of the Novo Group. Catalent, a global…

Read MoreEU Approves Novo Holdings’ Catalent Acquisition and Novo Nordisk’s Site Purchase
  • Press ReleasesBusiness

CVS Health Corporation Announces Pricing for Comprehensive Tender Offer

  • The Pharma Data
  • December 7, 2024

CVS Health Corporation has disclosed the Reference Yield and Total Consideration for its previously announced cash tender offer (the “Any and All Tender Offer”) targeting its 4.100% Senior Notes due…

Read MoreCVS Health Corporation Announces Pricing for Comprehensive Tender Offer
  • Business

AstraZeneca Appoints Iskra Reic as EVP, International

  • The Pharma Data
  • December 5, 2024

AstraZeneca announced the appointment of Iskra Reic as Executive Vice President (EVP), International, effective immediately. Reic will oversee the company’s strategy and growth across the vast International region, including markets…

Read MoreAstraZeneca Appoints Iskra Reic as EVP, International
  • Press Releases

WHO Prequalifies First Single-Dose Medicine for P. vivax Malaria and Includes it in Guidelines

  • The Pharma Data
  • December 5, 2024

GSK plc and Medicines for Malaria Venture (MMV) have announced a major milestone in the fight against malaria, as the World Health Organization (WHO) has awarded prequalification to tafenoquine. This…

Read MoreWHO Prequalifies First Single-Dose Medicine for P. vivax Malaria and Includes it in Guidelines
PrevNext
UK Biotech Day
Global Clinical
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Bio-Techne Expands COMET™ Suite with Modular Innovations to Advance Spatial Biology
  • WuXi Biologics Reports Record 2025 Annual Results, Fueled by Operational Excellence and Digital-Native Innovation
  • Pet Partners and the Baxter Foundation Expand Therapy Animal Programs to Reach 100,000 Patients and Healthcare Workers in Two-Year Pilot
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.